Cancer Research AACR Membership EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jang, J.-H.
Right arrow Articles by Park, J.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jang, J.-H.
Right arrow Articles by Park, J.-G.
[Cancer Research 61, 3541-3543, May 1, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Mutations in Fibroblast Growth Factor Receptor 2 and Fibroblast Growth Factor Receptor 3 Genes Associated with Human Gastric and Colorectal Cancers1

Jun-Hyeog Jang, Ki-Hyuk Shin and Jae-Gahb Park2

Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-744, Korea [J-H. J., K-H. S., J-G. P.], and National Cancer Center, Koyang, Kyunggi 411-351, Korea [J-G. P.]

Autosomal dominant disorders of skeletal and cranial development have been linked to fibroblast growth factor receptor (FGFR) 2 and FGFR3. Here we report two identical mutations in FGFR2 that cause craniosynostosis syndromes, Crouzon, Apert, and Pfeiffer in gastric carcinoma. A missense mutation (Ser267Pro) in exon IIIa and a splice site mutation (940–2A->G) in exon IIIc were detected in gastric cancer patients. Interestingly, these heterozygous somatic mutations are identical to the germinal activating mutations in FGFR2 reported previously in craniosynostosis syndromes. In addition, the two novel mutations of FGFR3 in colorectal carcinomas were identified. All identified mutations occurred at highly conserved sequences, not only in the FGFR family of molecules, but also throughout evolution and clustered in the immunoglobulin-like loop-III domain, highlighting the functional importance of this domain. Our results indicate that FGFR2 and FGFR3, in addition to their potential role in skeletal dysplasias, play an important role in tumorigenesis.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
S. Ota, Z.-Q. Zhou, J. M. Link, and P. J. Hurlin
The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects
Hum. Mol. Genet., July 15, 2009; 18(14): 2609 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. S. Udler, K. B. Meyer, K. A. Pooley, E. Karlins, J. P. Struewing, J. Zhang, D. R. Doody, S. MacArthur, J. Tyrer, P. D. Pharoah, et al.
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation
Hum. Mol. Genet., May 1, 2009; 18(9): 1692 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
R. Menezes, M. L. Marazita, T. G. McHenry, M. E. Cooper, K. Bardi, C. Brandon, A. Letra, R. A. Martin, and A. R. Vieira
AXIS inhibition protein 2, orofacial clefts and a family history of cancer
J Am Dent Assoc, January 1, 2009; 140(1): 80 - 84.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Huynh, V. C. Ngo, J. Fargnoli, M. Ayers, K. C. Soo, H. N. Koong, C. H. Thng, H. S. Ong, A. Chung, P. Chow, et al.
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Clin. Cancer Res., October 1, 2008; 14(19): 6146 - 6153.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Dutt, H. B. Salvesen, T.-H. Chen, A. H. Ramos, R. C. Onofrio, C. Hatton, R. Nicoletti, W. Winckler, R. Grewal, M. Hanna, et al.
Drug-sensitive FGFR2 mutations in endometrial carcinoma
PNAS, June 24, 2008; 105(25): 8713 - 8717.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Raskin, M. Pinchev, C. Arad, F. Lejbkowicz, A. Tamir, H. S. Rennert, G. Rennert, and S. B. Gruber
FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli Populations
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1060 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Kunii, L. Davis, J. Gorenstein, H. Hatch, M. Yashiro, A. Di Bacco, C. Elbi, and B. Lutterbach
FGFR2-Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
Cancer Res., April 1, 2008; 68(7): 2340 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
D. R. Berk, E. B. Spector, and S. J. Bayliss
Familial Acanthosis Nigricans Due to K650T FGFR3 Mutation
Arch Dermatol, September 1, 2007; 143(9): 1153 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Thussbas, J. Nahrig, S. Streit, J. Bange, M. Kriner, R. Kates, K. Ulm, M. Kiechle, H. Hoefler, A. Ullrich, et al.
FGFR4 Arg388 Allele Is Associated With Resistance to Adjuvant Therapy in Primary Breast Cancer
J. Clin. Oncol., August 10, 2006; 24(23): 3747 - 3755.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Davies, C. Hunter, R. Smith, P. Stephens, C. Greenman, G. Bignell, J. Teague, A. Butler, S. Edkins, C. Stevens, et al.
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Cancer Res., September 1, 2005; 65(17): 7591 - 7595.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. N. Meyer, R. F. Gastwirt, D. D. Schlaepfer, and D. J. Donoghue
The Cytoplasmic Tyrosine Kinase Pyk2 as a Novel Effector of Fibroblast Growth Factor Receptor 3 Activation
J. Biol. Chem., July 2, 2004; 279(27): 28450 - 28457.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. R. Qian, T. Sano, S. L. Asa, S. Yamada, H. Horiguchi, T. Tashiro, C. C. Li, M. Hirokawa, K. Kovacs, and S. Ezzat
Cytoplasmic Expression of Fibroblast Growth Factor Receptor-4 in Human Pituitary Adenomas: Relation to Tumor Type, Size, Proliferation, and Invasiveness
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1904 - 1911.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. Goriely, G. A. T. McVean, M. Rojmyr, B. Ingemarsson, and A. O. M. Wilkie
Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line
Science, August 1, 2003; 301(5633): 643 - 646.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ruehl, R. Somasundaram, I. Schoenfelder, R. W. Farndale, C. G. Knight, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan
The Epithelial Mitogen Keratinocyte Growth Factor Binds to Collagens via the Consensus Sequence Glycine-Proline-Hydroxyproline
J. Biol. Chem., July 19, 2002; 277(30): 26872 - 26878.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Nicholes, S. Guillet, E. Tomlinson, K. Hillan, B. Wright, G. D. Frantz, T. A. Pham, L. Dillard-Telm, S. P. Tsai, J.-P. Stephan, et al.
A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice
Am. J. Pathol., June 1, 2002; 160(6): 2295 - 2307.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Bange, D. Prechtl, Y. Cheburkin, K. Specht, N. Harbeck, M. Schmitt, T. Knyazeva, S. Muller, S. Gartner, I. Sures, et al.
Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg388 Allele
Cancer Res., February 1, 2002; 62(3): 840 - 847.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.